Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound Paclitaxel + Gemcitabine 3-week vs 4-week in Pancreatic Cancer
NCT05035147Phase 4Recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Mar 2021
- Primary completion
- Apr 2026
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nab-paclitaxel in pancreatic cancer (PC), sponsored by Tianjin Medical University Cancer Institute and Hospital. Started Mar 2021; status: recruiting.
02
Drugs
nab-paclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT05035147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035147.